Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 34 studies | 83% ± 16% | |
granulocyte | 4 studies | 77% ± 21% | |
megakaryocyte-erythroid progenitor cell | 4 studies | 45% ± 17% | |
hematopoietic precursor cell | 3 studies | 29% ± 14% |
Insufficient scRNA-seq data for expression of CPA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3098.13 | 576 / 578 | 85% | 39.86 | 976 / 1155 |
pancreas | 98% | 626.14 | 320 / 328 | 85% | 37.29 | 151 / 178 |
prostate | 94% | 1292.83 | 231 / 245 | 82% | 22.20 | 414 / 502 |
stomach | 99% | 1412.83 | 355 / 359 | 65% | 18.68 | 185 / 286 |
breast | 88% | 775.18 | 402 / 459 | 75% | 38.59 | 843 / 1118 |
esophagus | 94% | 1699.47 | 1359 / 1445 | 69% | 15.22 | 126 / 183 |
bladder | 100% | 1969.86 | 21 / 21 | 52% | 14.78 | 263 / 504 |
intestine | 88% | 1334.40 | 846 / 966 | 61% | 15.38 | 322 / 527 |
uterus | 90% | 1032.65 | 153 / 170 | 47% | 11.15 | 218 / 459 |
kidney | 27% | 273.55 | 24 / 89 | 68% | 23.74 | 614 / 901 |
adipose | 94% | 1394.91 | 1132 / 1204 | 0% | 0 | 0 / 0 |
skin | 70% | 976.04 | 1262 / 1809 | 11% | 1.70 | 53 / 472 |
tonsil | 0% | 0 | 0 / 0 | 62% | 14.86 | 28 / 45 |
blood vessel | 61% | 452.44 | 816 / 1335 | 0% | 0 | 0 / 0 |
thymus | 11% | 47.00 | 69 / 653 | 22% | 3.80 | 131 / 605 |
liver | 16% | 58.60 | 37 / 226 | 12% | 2.71 | 48 / 406 |
heart | 22% | 79.53 | 189 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 18% | 85.44 | 165 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 4.29 | 3 / 258 | 17% | 3.65 | 38 / 230 |
ovary | 11% | 53.72 | 20 / 180 | 6% | 0.67 | 26 / 430 |
spleen | 9% | 42.63 | 22 / 241 | 0% | 0 | 0 / 0 |
muscle | 8% | 27.10 | 63 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.93 | 2 / 29 |
brain | 0% | 0 | 0 / 2642 | 2% | 0.46 | 14 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002003 | Biological process | angiotensin maturation |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0030133 | Cellular component | transport vesicle |
GO_0030141 | Cellular component | secretory granule |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004181 | Molecular function | metallocarboxypeptidase activity |
Gene name | CPA3 |
Protein name | Mast cell carboxypeptidase A (MC-CPA) (EC 3.4.17.1) (Carboxypeptidase A3) |
Synonyms | |
Description | |
Accessions | P15088 ENST00000296046.4 |